Recent News 70 : Precise Health awarded for innovation in phage therapy

-

Precise Health awarded for innovation in phage therapy

The Valais-based startup Precise Health, supported by the Ark Foundation and based at the Energypolis campus in Sion, is racking up awards after awards. It recently received the Best Innovation Award at the 2025 Targeting Phage Therapy conference in Berlin. The company also received CHF 40,000 in support from the City of Sion's Innovation Boost Program, a program designed to encourage local economic development through innovative and sustainable projects.




The Targeting Phage Therapy Congress is the leading European event dedicated to phage therapy, a promising alternative to antibiotics for combating multidrug-resistant bacterial infections. The prize awarded to Precise Health recognizes the innovation of the young startup, an innovative digital platform capable of rapidly identifying the most suitable therapeutic phage for a given infection. This platform is based in particular on artificial intelligence and interconnection with global biobanks.

This technological advancement drastically reduces the time between diagnosis and treatment, a vital issue in the face of serious infections, which are often unresponsive to conventional treatments. According to the organizers of the Berlin conference, this solution represents a "major leap forward in the field of personalized antimicrobial therapies."

A financial boost to accelerate development

In addition to this scientific recognition, Precise Health was selected for the City of Zion's Innovation Boost Program . This program focuses on providing direct financial support to businesses through a seed fund.

With this support, the startup will be able to strengthen its strategic foundations, develop its partnerships, and continue implementing its technology, particularly through pilot clinical studies already planned. Learn more about the technology developed by Precise Health.


Taken from, copyright belongs to : https://theark.ch/fr/news/precise-health-recompensee-pour-son-innovation-en-therapie-phagique/

Comments

Post a Comment

Popular posts from this blog

History Part 12 : Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s)

-
Image
Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s) The period following World War II marked a decisive turning point in the trajectory of phage therapy in Western medicine. Despite the promising results bacteriophages had demonstrated prior to the war as potential antibacterial agents, the decades after 1945 saw a dramatic decline in interest, funding, and scientific engagement with phage therapy in the United States and much of Western Europe. This marginalization can be attributed to a confluence of scientific, sociopolitical, and economic factors that reshaped the landscape of infectious disease treatment and research. Artistic View One of the key contributors to this decline was the overwhelming optimism surrounding the newly discovered class of antibiotics. The post-war pharmaceutical revolution brought forward a series of broad-spectrum antibiotics such as streptomycin, tetracycline, and chloramphenicol, which were viewed as miracle drugs capable o...
Read more

The Phage Therapy in the spotlight !

-
Image
Bacteriophages: Ancient Predators and the Next Frontier in Medicine In the animated documentary The Deadliest Being on Planet Earth , the Kurzgesagt team delves into the world of bacteriophages—viruses that prey exclusively on bacteria. With vibrant visuals and precise narration, the video introduces viewers to an invisible ecosystem where microscopic hunters orchestrate life-and-death dramas that shape the biosphere. These entities, though virtually unknown to the general public, may soon become central to the future of medicine. At the heart of the video lies a paradox: bacteriophages (or "phages") are among the most abundant biological entities on Earth—outnumbering all other organisms combined—yet their therapeutic potential has been largely sidelined in the antibiotic era. The video outlines the historical trajectory of phage research, spotlighting Félix d’Hérelle’s early 20th-century work and the rise of phage therapy, only to show how it was later eclipsed by the dis...
Read more

Paper 3 : Phage Therapy May Treat Drug Resistance in Patients With Cystic Fibrosis, Study Finds

-
Image
Phage Therapy May Treat Drug Resistance in Patients With Cystic Fibrosis, Study Finds June 13, 2025 "Yale's university researchers find a new approach to combatting antimicrobial resistance. Antimicrobial resistance, in which germs like bacteria and fungi no longer respond to medicines, is a rising global threat. When antibiotics and other drugs become ineffective, infections can become difficult or impossible to treat, leading to an increase in the spread and severity of disease. In a new study, published in Nature Medicine , a team of researchers at the Center for Phage Biology and Therapy at Yale discovered a novel approach that may revolutionize the fight against antimicrobial resistance. Jon Koff, MD, with a patient Credit: Robert A. Lisak For the study, the research team investigated the use of phage therapy—the use of viruses, or phages, to target and kill bacteria—to help patients with cystic fibrosis, a disease in which antimicrobial resistance is a significant issue....
Read more